Download PDF
Arthritis und Rheuma 2012; 32(01): 42-44
DOI: 10.1055/s-0037-1618103
Kinder-rheumatologie: Kasuistik
Schattauer GmbH

Fluoreszenzoptisches Bildgebungssystem Xiralite® zur Einschätzung der Therapieeffizienz bei JIA

G. Horneff
1   Kinderrheumazentrum Sankt Augustin, Asklepios Klinik, Sankt Augustin
,
S. G. Werner
2   Medizinische Klinik mit Schwerpunkt Rheumatologie und klinische Immunologie, Universitätsmedizin Charité Campus Mitte, Berlin
,
H. E. Langer
3   RHIO (Rheumatologie, Immunologie, Osteologie) Düsseldorf
,
M. Backhaus
2   Medizinische Klinik mit Schwerpunkt Rheumatologie und klinische Immunologie, Universitätsmedizin Charité Campus Mitte, Berlin
› Author Affiliations
Further Information

Publication History

Publication Date:
21 December 2017 (online)

    Permissions and Reprints

 

 

  • Literatur

  • 1 Petty RE, Southwood TR, Manners P. et al. International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31 (02) 390-392.
    Google Scholar
  • 2 Klein A, Horneff G. Treatment strategies for juvenile idiopathic arthritis. Expert Opin Pharmacother 2009; 10 (18) 3049-3060.
    CrossrefPubMedGoogle Scholar
  • 3 Vilca I, Munitis PG, Pistorio A. et al. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Ann Rheum Dis 2010; 69 (08) 1479-8369.
    CrossrefPubMedGoogle Scholar
  • 4 Papsdorf V, Horneff G. Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis. Rheumatol (Oxford) 2011; 50 (01) 214-221.
    CrossrefPubMedGoogle Scholar
  • 5 Minden K, Niewerth M, Listing J. et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46 (09) 2392-2401.
    CrossrefPubMedGoogle Scholar
  • 6 Biswal S, Resnick DL, Hoffman JM, Gambhir SS. Molecular Imaging: Integration of Molecular Imaging into the Musculoskeletal Imaging Practice. Radiology 2007; 244 (03) 651-671.
    CrossrefPubMedGoogle Scholar
  • 7 Taylor PC, Steuer A, Gruber J. et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum 2004; 50 (04) 1107-1116.
    CrossrefPubMedGoogle Scholar
  • 8 Bremer C, Werner S, Langer HE. Assessing Activity of Rheumatic Arthritis with Fluorescence Optical Imaging. European Musculoskeletal Review 2009; 4 (02) 96-100.
    Google Scholar
  • 9 Fischer T, Ebert B, Voigt J. et al. Detection of Rheumatoid Arthritis Using Non-Specific Contrast Enhanced Fluorescence Imaging. Acad Radiol 2010; 17 (03) 375-381.
    CrossrefPubMedGoogle Scholar
  • 10 Werner SG, Langer HE, Ohrndorf S. et al. Inflammation assessment in patients with arthritis using novel in vivo fluorescence optical imaging technology. Ann Rheum Dis. 2011 Oct 12. [Epub ahead of print]
    PubMedGoogle Scholar
  • 11 Werner SG, Langer HE, Horneff G. Fluorescence optical imaging of juvenile arthritis. J Rheumatol 2011; 38 (07) 1447.
    CrossrefPubMedGoogle Scholar
  • 12 Dueckers G, Guellac N, Arbogast M. et al. Evidence and consensus based treatment guidelines 2010 for juvenile idiopathic arthritis by the German Society of Paediatric Rheumatology. Klin Padiatr 2011; 223 (06) 386-394.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Wallace CA, Ruperto N, Giannini E. et al. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31 (11) 2290-2294.
    Google Scholar
  • 14 Foell D, Wulffraat N, Wedderburn LR. et al Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 2010; 303 (13) 1266-1273.
    CrossrefPubMedGoogle Scholar